Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
40.74
+0.87 (2.18%)
Aug 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Small Molecule Therapeutics
47.07M
Log In
Log In
Log In
Log In
Upgrade
Small Molecule Therapeutics Growth
-40.11%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United States
47.07M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-40.11%
Log In
Log In
Log In
Log In
Upgrade